Article
EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
Cancer research and treatment - 1 Jul 2018
Yang Jiyoul, Lee Ok-Jun, Son Seung-Myoung, Woo Chang Gok, Jeong Yusook, Yang Yaewon, Kwon Jihyun, Lee Ki Hyeong, Han Hye Sook
Abstract excerpt
PURPOSE: Malignant pleural effusions (MPEs) are often observed in lung cancer, particularly adenocarcinoma. The aim of this study was to investigate epidermal growth factor receptor (EGFR) mutation status in lung adenocarcinoma-associated MPEs (LA-MPEs) and its correlation with efficacy of EGFR tyrosine kinase inhibitor (TKI) therapy. MATERIALS AND METHODS: Samples comprised 40 cell blocks of...
Topics
- Adenocarcinoma
- Adenocarcinoma of Lung
- Adult
- Aged
- Aged, 80 and over
- Disease Progression
- ErbB Receptors
- Female
- Humans
- Lung Neoplasms
- Male
